Table 3.
Immunosuppressors/immunomodulators during the admission.
| Without AD | Classical AD | Other AD | Miscellaneous AD | p-Value | |
|---|---|---|---|---|---|
| Hydroxychloroquine n (%) | 11,581 (85.6) | 172 (83.1) | 106 (79.1) | 19 (90.5) | 0.113 |
| Chloroquine n (%) | 622 (4.6) | 13 (6.3) | 9 (6.7) | 0 (0.0) | 0.310 |
| Tocilizumab n (%) | 1136 (8.4) | 19 (9.2) | 9 (6.7) | 3 (14.3) | 0.661 |
| Immunoglobulin n (%) | 58 (0.4) | 5 (2.4) | 1 (0.7) | 0 (0.0) | 0.001 |
| Anakinra n (%) | 75 (0.6) | 2 (1.0) | 0 (0.0) | 0 (0.0) | 0.685 |
| Baricitinib n (%) | 77 (0.6) | 3 (1.4) | 0 (0.0) | 1 (4.8) | 0.020 |
| Corticosteroids n (%) | 4656 (34.5) | 102 (49.3) | 49 (36.6) | 11 (52.4) | <0.001 |
AD: autoimmune diseases.